Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/54515
Title: Nationwide COVID-19-EII Study: incidence, environmental risk factors and long-term follow-up of patients with inflammatory bowel disease and COVID-19 of the ENEIDA registry
Authors: 
Zabana, Yamile
Marín-Jiménez, Ignacio
Rodríguez-Lago, Iago
Vera, Isabel
Martín-Arranz, María Dolores
Guerra, Ivan
Gisbert, Javier Pérez
Mesonero, Francisco
Benítez, Olga
Taxonera, Carlos
Ponferrada-Díaz, Ángel
Piqueras, Marta
Lucendo, Alfredo J
Caballol, Berta
Mañosa, Míriam
Martínez-Montiel, Pilar
Boscá-Watts, Marta Maia
Gordillo, Jordi
Bujanda, Luis
Manceñido, Noemí
Martínez-Pérez, Teresa
López, Alicia
Rodríguez-Gutiérrez, Cristina
García-López, Santiago
Vega, Pablo
Rivero, Montserrat
Melcarne, Luigi
Calvo, Maria
Iborra, Marisa
Barreiro de-Acosta, Manuel
Sicilia, Beatriz
Barrio, Jesús
Pérez, José Lázaro
Busquets, David
Pérez-Martínez, Isabel
Navarro-Llavat, Mercè
Hernández, Vicent
Argüelles-Arias, Federico
Ramírez Esteso, Fernando
Meijide, Susana
Ramos, Laura
Gomollón, Fernando
Muñoz, Fernando
Suris, Gerard
de Zarate, Jone Ortiz
Huguet, José María
Llaó, Jordina
García-Sepulcre, Mariana Fe
Sierra, Mónica
Durà, Miguel
Estrecha, Sandra
Fuentes Coronel, Ana María
Hinojosa, Esther
Olivan, Lorenzo
Iglesias, Eva
Gutiérrez, Ana
Varela, Pilar
Rull, Núria
Gilabert, Pau
Hernández-Camba, Alejandro
Brotons, Alicia
Ginard, Daniel
Sesé, Eva
Carpio, Daniel
Aceituno, Montserrat
Cabriada, José Luis
González-Lama, Yago
Jiménez, Laura
Chaparro, María
López-San Román, Antonio
Alba, Cristina
Plaza-Santos, Rocío
Mena, Raquel
Tamarit-Sebastián, Sonsoles
Ricart, Elena
Calafat, Margalida
Olivares, Sonsoles
Navarro, Pablo
Bertoletti, Federico
Alonso-Galán, Horacio
Pajares Villarroya, Ramón
Olcina, Pablo
Manzano, Pamela
Domènech, Eugeni
Esteve, Maria
ENEIDA Registry GETECCU
Filiation: Servicio de Digestivo. Hospital Universitario de Fuenlabrada
Keywords: 
Mesh: 
Decs: Enfermedades Inflamatorias del Intestino
Infecciones por Coronavirus
Issue Date: 14-Jan-2022
Citation: Zabana Y, Marín-Jiménez I, Rodríguez-Lago I, Vera I, Martín-Arranz MD, Guerra Marina I, et al. Nationwide COVID-19-EII Study: incidence, environmental risk factors and long-term follow-up of patients with inflammatory bowel disease and COVID-19 of the ENEIDA registry. J Clin Med. 2022;11(2):421.
Abstract: We aim to describe the incidence and source of contagion of COVID-19 in patients with IBD, as well as the risk factors for a severe course and long-term sequelae. This is a prospective observational study of IBD and COVID-19 included in the ENEIDA registry (53,682 from 73 centres) between March-July 2020 followed-up for 12 months. Results were compared with data of the general population (National Centre of Epidemiology and Catalonia). A total of 482 patients with COVID-19 were identified. Twenty-eight percent were infected in the work environment, and 48% were infected by intrafamilial transmission, despite having good adherence to lockdown. Thirty-five percent required hospitalization, 7.9% had severe COVID-19 and 3.7% died. Similar data were reported in the general population (hospitalisation 19.5%, ICU 2.1% and mortality 4.6%). Factors related to death and severe COVID-19 were being aged ≥ 60 years (OR 7.1, 95% CI: 1.8-27 and 4.5, 95% CI: 1.3-15.9), while having ≥2 comorbidities increased mortality (OR 3.9, 95% CI: 1.3-11.6). None of the drugs for IBD were related to severe COVID-19. Immunosuppression was definitively stopped in 1% of patients at 12 months. The prognosis of COVID-19 in IBD, even in immunosuppressed patients, is similar to that in the general population. Thus, there is no need for more strict protection measures in IBD.
PMID: 35054116
URI: https://hdl.handle.net/20.500.12530/54515
Rights: info:eu-repo/semantics/openAccess
Appears in Collections:Hospitales > H. U. de Fuenlabrada > Artículos

Files in This Item:
File Description SizeFormat 
JCM.pdf1.01 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons